| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1377580B1 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 09/27/2006 | EP1374899B1 Remedies for post-traumatic stress disorder |
| 09/27/2006 | EP1368008B1 Transdermal therapeutic system for the administration of the partial dopamine-d2 agonist aripiprazol |
| 09/27/2006 | EP1335906B1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 09/27/2006 | EP1303537B1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | EP1196433B1 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 09/27/2006 | EP1123088B1 Sustained-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
| 09/27/2006 | EP0983765B1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance |
| 09/27/2006 | CN1839149A Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 09/27/2006 | CN1838965A Drug for cancer therapy |
| 09/27/2006 | CN1838946A Pharmaceutical formulations of amyloid inhibiting compounds |
| 09/27/2006 | CN1837207A Pirazino(aza)indole derivatives |
| 09/27/2006 | CN1837197A Salvianolic acid M and rosmarinic acid as aldose reductase inhibitor in sage |
| 09/27/2006 | CN1837195A Pyridine derivatives as nmda-receptor subtype blockers |
| 09/27/2006 | CN1836682A Gadol drop pills and preparation method thereof |
| 09/27/2006 | CN1836678A Tablet spirulina spp for invigorating yang , and its preparation method |
| 09/27/2006 | CN1836677A Substance and technology for producing substance capable of repairing pathogenic gene not using clone technology |
| 09/27/2006 | CN1836661A Use of aconine in medicine manufacture |
| 09/27/2006 | CN1836568A Wild rose health food and preparation method thereof |
| 09/27/2006 | CN1836567A Health food for adjusting female physiological function |
| 09/27/2006 | CN1836530A Lucid ganoderma dairy produce series and its production method |
| 09/27/2006 | CN1276974C Gsk3 polypeptides |
| 09/27/2006 | CN1276911C New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method |
| 09/27/2006 | CN1276758C Compound preparation of Chinese traditional medicine for curing chronic fatigue syndrome and its preparation method |
| 09/27/2006 | CN1276748C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 09/26/2006 | US7112683 Cyclic sulfone containing retroviral protease inhibitors |
| 09/26/2006 | US7112666 Von Willebrand Factor (Vwf)-cleaving protease |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112611 Antitumor, anticancer agents; respiratory system disorders; brain disorders |
| 09/26/2006 | US7112607 Antihypoxic agents, antiischamic agents, antiarrhythmia agents |
| 09/26/2006 | US7112606 Heterocyclic arylsulfonamidobenzylic compounds |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112598 κ opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/26/2006 | US7112594 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents |
| 09/26/2006 | US7112593 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 09/26/2006 | US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
| 09/26/2006 | US7112582 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics |
| 09/26/2006 | US7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 09/26/2006 | US7112574 found to be potent adenosine receptor agonists, in particular for the A2A receptor. |
| 09/26/2006 | US7112568 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 09/26/2006 | US7112565 Stabilized pharmaceutical composition in lyophilized form |
| 09/26/2006 | US7112430 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 09/26/2006 | US7112427 Protein comprising mitogenic kinase activity for identifying modulators of inflammation, apoptosis and cell proliferation; antiproliferative agents |
| 09/26/2006 | US7112337 Liposome mixture of a lipid that is neutral in charge at physiologic pH and positively charged at pH values less than physiological pH, and a lipid joined to a hydrophilic polymer by an aromatic disulfide linkage, associated with a nucleic |
| 09/26/2006 | CA2278694C Sulfamide-metalloprotease inhibitors |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006098524A1 Prophylactic/therapeutic agent for stress-induced bowel disease |
| 09/21/2006 | WO2006098465A1 Prophylactic/therapeutic agent for cancer |
| 09/21/2006 | WO2006098394A1 Method for inhibiting lipid absorption and lipid absorption inhibitor |
| 09/21/2006 | WO2006098353A1 External preparation |
| 09/21/2006 | WO2006098332A1 Promoter for hard tissue formation |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006098304A1 Novel secretory protein derived from pituitary cell and use of the same |
| 09/21/2006 | WO2006098292A1 Therapeutic agent for ophthalmic disease |
| 09/21/2006 | WO2006097970A1 Use of inhibitors of steroid (testosterone) activity (i. a. estrogens) or antiandrogens) for treatment of substance correlated disorders like drug abuse |
| 09/21/2006 | WO2006049957A3 Method for treating glioma |
| 09/21/2006 | WO2006046734A3 Novel aminopyridine derivatives having selective aurora-a inhibitory effect |
| 09/21/2006 | US20060212109 Delivery of therapeutic capable agents |
| 09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211719 Heteroaryl aminoguanidine and alkoxyguanidines and their use as protease inhibitors |
| 09/21/2006 | US20060211717 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/21/2006 | US20060211704 2,4-Disubstituted thiazolyl derivatives |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211679 Substituted lactams as inhibitors of Abeta protein production |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | US20060211674 Combination comprising a vasculostatic compound and an alkylating agent for the treatment of a tumor |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211663 Low dose estrogen interrupted hormone replacement therapy |
| 09/21/2006 | US20060211659 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof |
| 09/21/2006 | US20060211654 Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor |
| 09/21/2006 | US20060211651 Persulfated oligosaccharide acting on selectins and chemokine |
| 09/21/2006 | US20060211638 Exon 1 ss of pdgf alpha gene and utilization thereof |
| 09/21/2006 | US20060211637 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 09/21/2006 | US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/21/2006 | US20060211609 Novel agent for improving neurotransmission failure |
| 09/21/2006 | US20060211602 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | US20060211090 Human cDNAs and proteins and uses thereof |
| 09/21/2006 | US20060211025 Molecular signatures of commonly fatal carcinomas |
| 09/21/2006 | US20060210656 Synergistic Effects of Nuclear Transcription Factor NF-kB Inhibitors and Anti-Neoplastic Agents |
| 09/21/2006 | US20060210641 Absorbable microparticles |
| 09/21/2006 | US20060210593 Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same |
| 09/21/2006 | US20060210575 Cytotoxic protein and utilization thereof |
| 09/21/2006 | US20060210565 Antagonists of HMG1 for treating inflammatory conditions |
| 09/21/2006 | US20060210564 Novel diabody-type bispecific antibody |
| 09/21/2006 | US20060210561 Dosages for treatment with anti-EGFR antibodies |
| 09/21/2006 | US20060210531 Agent eleveting dendritic cell precursor level in blood |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2601123A1 External preparation |